On March, 15, 2018, the first participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. As of March 19, 2018, a total of 43 people have completed preliminary phone screening for enrollment opportunities. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients.
Learn more…